Related Experiment Video

Updated: May 31, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
07:01

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

Published on: September 11, 2020

Molecular markers of kidney injury

Brian R Lane1

  • 1Urology Division, Spectrum Health Hospital System, Grand Rapids, MI 49546, USA. brian.lane@spectrumhealth.org

Urologic Oncology
|July 5, 2011
PubMed

Insights

Acute kidney injury is common after nephrectomy for kidney cancer. Novel molecular markers like NGAL and KIM-1 may better detect kidney damage than traditional measures, aiding research for improved patient outcomes.

Area of Science:

  • Urology
  • Nephrology
  • Biomarker Research

Background:

  • Renal dysfunction frequently affects urologic patients, particularly after nephrectomy for renal cancer.
  • Partial nephrectomy preserves renal function better than radical nephrectomy but carries risks of acute kidney injury (AKI) from nephron loss and ischemia.
  • Current clinical markers (serum creatinine, urine output) may not reliably detect AKI, potentially delaying crucial interventions.

Purpose of the Study:

  • To highlight the limitations of conventional clinical parameters in assessing ischemic and tubular injury post-nephrectomy.
  • To introduce novel molecular markers for improved quantification of kidney injury.
  • To emphasize the potential of these markers in advancing research for better patient outcomes after partial nephrectomy.

Main Methods:

  • Review of current clinical parameters for assessing renal function and kidney injury.
  • Identification and discussion of emerging molecular markers: cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), IL-18, and kidney injury molecule-1 (KIM-1).
  • Comparison of the diagnostic capabilities of molecular markers versus traditional clinical assessments.

Main Results:

  • Conventional clinical parameters like serum creatinine and urine output may not accurately reflect the extent of acute ischemic or tubular injury.
  • Molecular markers (cystatin C, NGAL, IL-18, KIM-1) demonstrate superior ability in quantifying acute kidney injury.
  • These markers offer a more sensitive and timely assessment of kidney damage compared to existing methods.

Conclusions:

  • Novel molecular markers provide a more precise assessment of acute kidney injury following partial nephrectomy.
  • Early and accurate detection of kidney damage using these markers is crucial for research and clinical management.
  • Further research utilizing these biomarkers can lead to improved strategies for preserving renal function in urologic oncology patients.

More Related Videos

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...